KRPIA member companies spending 122 billion won for R&D

Published: 2006-03-02 06:57:00

Updated: 2006-03-02 06:57:00

President Maag Timney of KRPIA said on Feb. 24 by quoting the latest statistics released in the United States that the PhRMA, an American research based pharmaceutical corporation group, spent about $39.4 billion (39,400 billion won) for the R&D of the biomedical and other new drugs in 2005, 6.5%...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK